Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate, treat and follow patients with parasitic infections.
People with a known or suspected parasitic infection who are at least 1 year old may be enrolled. This study does not involve any experimental treatments.
Participants will have a physical examination and laboratory tests on blood, stool, or urine. Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds) of body weight from children, in any 6-week period. Other tests may include x-rays, electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample), depending on the individual s condition.
Patients may be offered treatment or may be referred to another study that is more appropriate for the problem. Any treatment provided in this study will be according to standard medical practice for the patient s specific medical problem. Patients responses to treatment will be evaluated at regularly scheduled clinic visits. The length of time between visits and the total duration of the study for a given individual will be determined by the study doctor, based on that person s medical condition.
| Condition |
|---|
|
Parasitic Disease |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Evaluation, Treatment, and Monitoring of Patients With Known or Suspected Parasitic Infection |
- To evaluate, treat and follow patients with parasitic infections not covered by existing LPD/NIAID protocols [ Time Frame: Continuous ] [ Designated as safety issue: No ]
- To screen patients with suspected parasitic infections for enrollment on other LPD/NIAID protocols [ Time Frame: Continuous ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 500 |
| Study Start Date: | March 1997 |
Eligibility| Ages Eligible for Study: | 1 Year and older (Child, Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
- INCLUSION CRITERIA:
Age 1 or over.
Access to a primary medical care provider outside of the NIH.
Ability to give written informed consent (for adults) and parental consent (for those under 18).
Clinical evidence suggestive of a parasitic infection.
EXCLUSION CRITERIA:
Less than 1 year of age.
No evidence suggestive of a parasitic infection.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00001645
| Contact: Thomas W Brown, R.N. | (301) 402-7823 | thomas.brown2@nih.gov | |
| Contact: Thomas B Nutman, M.D. | (301) 496-5399 | tnutman@mail.nih.gov |
| United States, Maryland | |
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Recruiting |
| Bethesda, Maryland, United States, 20892 | |
| Contact: For more information at the NIH Clinical Center contact Patient Recruitment and Public Liaison Office (PRPL) 800-411-1222 ext TTY8664111010 prpl@mail.cc.nih.gov | |
| Principal Investigator: | Thomas B Nutman, M.D. | National Institute of Allergy and Infectious Diseases (NIAID) |
More Information
Additional Information:
Publications:
| Responsible Party: | National Institute of Allergy and Infectious Diseases (NIAID) |
| ClinicalTrials.gov Identifier: | NCT00001645 History of Changes |
| Other Study ID Numbers: | 970096 97-I-0096 |
| Study First Received: | November 3, 1999 |
| Last Updated: | August 31, 2016 |
| Health Authority: | United States: Federal Government |
Keywords provided by National Institutes of Health Clinical Center (CC):
|
Chagas' Disease Trypanosomiasis Malaria Parasitic Infection |
Additional relevant MeSH terms:
|
Infection Parasitic Diseases |
ClinicalTrials.gov processed this record on September 30, 2016